Trial Profile
A Phase 2, Double-Blind, Placebo-Controlled, Randomised, Single Dose, Crossover Study to Investigate the Glucose Lowering of PSN821 in Patients with Type 2 Diabetes (T2DM) after an Ensure Plus challenge
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2012
Price :
$35
*
At a glance
- Drugs PSN 821 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Prosidion
- 22 Apr 2012 New trial record